22 results
6-K
STVN
Stevanato Group Spa
9 May 24
Current report (foreign)
4:10pm
innovation, acceleration and expansion of vaccination programs, growth in biologics/biosimilars, self-administration of medicines, aging demographics
424B5
STVN
Stevanato Group Spa
25 Mar 24
Prospectus supplement for primary offering
4:04pm
, growth of biologics/biosimilars, self-administration of medicines, aging demographics, increasing complexities in health conditions and co
424B5
STVN
Stevanato Group Spa
20 Mar 24
Prospectus supplement for primary offering
5:16pm
/biosimilars, self-administration of medicines, aging demographics, increasing complexities in health conditions and co-morbidities, and increasing quality
6-K
STVN
Stevanato Group Spa
3 Nov 23
Current report (foreign)
4:00pm
/biosimilars, self-administration of medicines, aging demographics, increasing quality standards and regulation and a shift towards outsourcing non-core
6-K
EX-99.1
vhholio1d37lv6 ko
28 Sep 23
Current report (foreign)
9:31am
6-K
q307bwn6 5jb
2 Aug 23
Current report (foreign)
9:25am
6-K
9a8h2kjtw6g 8bx
4 May 23
Current report (foreign)
7:49am
6-K
riiwqo tojc
8 Nov 22
Current report (foreign)
6:47am
6-K
ge17p17j0f8q
4 Aug 22
Current report (foreign)
6:47am
6-K
aqxlz0vf35reny4x7yig
10 May 22
Current report (foreign)
8:20am
6-K
EX-99.2
qwgh7j lrk3l
6 May 22
Ordinary and Extraordinary Shareholders’ Meeting
6:07am
20-F/A
kikcui5ilwk85zz
5 Apr 22
Annual report (foreign) (amended)
7:14am
20-F
v4nxv 6spdzdxe7c9x31
8 Mar 22
Annual report (foreign)
6:50am
6-K
dnnhk9o0
9 Nov 21
Current report (foreign)
4:35pm
6-K
qsrgxu 09p7
23 Aug 21
Current report (foreign)
10:27am
424B4
md2 2dddzsh7
16 Jul 21
Prospectus supplement with pricing info
2:18pm
F-1/A
9wnmymy8bcytrajdxc
12 Jul 21
Registration statement (foreign) (amended)
7:22am
F-1/A
4hg8loiwa6tc2rsn
7 Jul 21
Registration statement (foreign) (amended)
9:59am
F-1
zo4pje7mane8k9z3jo4t
21 Jun 21
Registration statement (foreign)
8:54am